GlassScriptPhysician profile
Kelsey Sammet
NPI 1306518634
$3,430.63
in general payments reported to CMS, 2019-2025
22 companies · $215 in 2025
The $215 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $145 · 2022: $413 · 2023: $638 · 2024: $2,018 · 2025: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,437 · Food and Beverage: $1,435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,437.18 |
| Food and Beverage | $1,434.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,890.54 | 2023-2024 | Axonics, Bulkamid |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $463.20 | 2021-2023 | Lifevest |
| Sumitomo Pharma America, INC. | $246.98 | 2024-2025 | Gemtesa |
| Edwards Lifesciences Corporation | $108.80 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Pfizer INC. | $104.90 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $82.30 | 2021-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $78.05 | 2021-2023 | Brilinta, Farxiga |
| E.R. Squibb & Sons, L.L.C. | $66.39 | 2022-2023 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.71 | 2022-2023 | Jardiance |
| Abbvie INC. | $44.48 | 2025 | |
| Boston Scientific Corporation | $40.51 | 2022 | |
| Sanofi-Aventis U.S. LLC | $35.53 | 2023 | |
| Amgen INC. | $33.87 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $33.65 | 2022 | |
| Merck Sharp & Dohme LLC | $29.93 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $28.81 | 2023 | Injectafer |
| Abc Home Medical Supply, INC. | $17.57 | 2025 | |
| Coloplast Corp | $17.11 | 2025 | |
| Getinge USA Sales, LLC | $15.38 | 2021 | |
| Cardiva Medical, INC. | $14.68 | 2022 | |
| Novartis Pharmaceuticals Corporation | $14.14 | 2022 | |
| Cvrx, INC. | $13.10 | 2023 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelsey Sammet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.